Evidence map›Paper›PMID 35806341›Full record

ArticleInternational journal of molecular sciences2022

Chronic Immune Platelet Activation Is Followed by Platelet Refractoriness and Impaired Contractility.

Izabella A Andrianova, Alina I Khabirova, Anastasia A Ponomareva, Alina D Peshkova, Natalia G Evtugina, Giang Le Minh, Timur B Sibgatullin, John W Weisel, Rustem I Litvinov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Blood clot contraction: Mechanisms, pathophysiology, and disease.Research and practice in thrombosis and haemostasis · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Izabella A AndrianovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Alina I KhabirovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Anastasia A PonomarevaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Alina D PeshkovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0002-8790-1818
Natalia G EvtuginaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Giang Le MinhInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Timur B SibgatullinDepartment of Rheumatology, University Hospital, Kazan Federal University, 420097 Kazan, Russia.
John W WeiselDepartment of Cell and Developmental Biology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6058, USA.
Rustem I LitvinovDepartment of Cell and Developmental Biology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6058, USA.ORCID 0000-0003-0643-1496
Kazan Federal University · RUUniversity of Pennsylvania · US

Funding

Subcellular Mechanisms pf Platelet ActivationP01HL040387 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PONCZ, MORTIMER · 1988 to 2018
$35.5M
Mechanisms of mechano-chemical rupture of blood clots and thrombiR01HL148227 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PUROHIT, PRASHANT KISHORE · 2020 to 2023
$2.5M
The Novel Mechanisms of Thrombosis Formation in Myeloproliferative DiseasesR01HL148014 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ABRAMS, CHARLES S. · 2020 to 2023
$2.5M
NHLBI NIH HHS P01 HL040387NHLBI NIH HHS R01 HL148014NHLBI NIH HHS R01 HL148227NIH HHS grants RO1-HL148227, P01-HL40387, and RO1-HL148014
6 · The paper itself

Abstract

Autoimmune diseases, including systemic lupus erythematosus (SLE), have a high risk of thrombotic and hemorrhagic complications associated with altered platelet functionality. We studied platelets from the blood of SLE patients and their reactivity. The surface expression of phosphatidylserine, P-selectin, and active integrin αIIbβ3 were measured using flow cytometry before and after platelet stimulation. Soluble P-selectin was measured in plasma. The kinetics of platelet-driven clot contraction was studied, as well as scanning and transmission electron microscopy of unstimulated platelets. Elevated levels of membrane-associated phosphatidylserine and platelet-attached and soluble P-selectin correlated directly with the titers of IgG, anti-dsDNA-antibodies, and circulating immune complexes. Morphologically, platelets in SLE lost their resting discoid shape, formed membrane protrusions and aggregates, and had a rough plasma membrane. The signs of platelet activation were associated paradoxically with reduced reactivity to a physiological stimulus and impaired contractility that revealed platelet exhaustion and refractoriness. Platelet activation has multiple pro-coagulant effects, and the inability to fully contract (retract) blood clots can be either a hemorrhagic or pro-thrombotic mechanism related to altered clot permeability, sensitivity of clots to fibrinolysis, obstructiveness, and embologenicity. Therefore, chronic immune platelet activation followed by secondary platelet dysfunction comprise an understudied pathogenic mechanism that supports hemostatic disorders in autoimmune diseases, such as SLE.

Indexed as

Autoimmune DiseasesLupus Erythematosus, SystemicThrombosisBlood PlateletsHumansPhosphatidylserinesPlatelet ActivationP-SelectinPhosphatidylserinesP-Selectinchronic immune inflammationclot contractionhemostatic disordersplateletssystemic lupus erythematosus

Identifiers

PMID35806341
PMCPMC9266422
OpenAlexW4283752327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.